AAAAAA
Results: 1-25/191
Citation: 18th international conference on human markers - Abstracts (oral presentations), J TUMOR M, 16(2), 2001, pp. 102
Authors:
Birkmayer, GD
Citation: Gd. Birkmayer, Birthday celebration - Prof. Janis V. Klavins, MD, PhD, J TUMOR M, 16(2), 2001, pp. 145-146
Authors:
Yasasever, V
Ozcan, F
Camlica, H
Nane, I
Dalay, N
Citation: V. Yasasever et al., New urinary antigens as markers in bladder cancer, J TUMOR M, 16(2), 2001, pp. 147-152
Authors:
Mor, C
Concas, D
Bailo, M
Biancardi, C
Bissi, O
Botta, M
Di Mattia, D
Ferrara, RM
Gariboldi, A
Ratti, C
Renzetti, D
Santi, C
Bartorelli, A
Citation: C. Mor et al., The association of enhanced survival with UK101 immunotherapy in metastatic cancer, J TUMOR M, 16(2), 2001, pp. 153-160
Authors:
Kshivets, O
Citation: O. Kshivets, Immune cell and humoral circuit in prediction of non-small cell lung cancer patients survival after complete resections, J TUMOR M, 16(2), 2001, pp. 161-174
Authors:
Klavins, JV
Citation: Jv. Klavins, Birthday celebration Prof. Dr. George Birkmayer, J TUMOR M, 16(1), 2001, pp. 5-6
Authors:
Jorgensen, LGM
Citation: Lgm. Jorgensen, Foreword, J TUMOR M, 16(1), 2001, pp. 7-7
Authors:
Jorgensen, LGM
Citation: Lgm. Jorgensen, Neuron specific enolase (NSE) as prognostic factor in small cell lung cancer (SCLC), J TUMOR M, 16(1), 2001, pp. 9-12
Authors:
Jorgensen, LGM
Brandslund, I
Citation: Lgm. Jorgensen et I. Brandslund, Evaluation of tumour markers and clinical needs, J TUMOR M, 16(1), 2001, pp. 13-16
Authors:
Olesen, F
Citation: F. Olesen, Tumor markers in screening and case finding in primary health care, J TUMOR M, 16(1), 2001, pp. 17-21
Authors:
Pujol, JL
Boher, JM
Quantin, X
Grenier, J
Daures, JP
Citation: Jl. Pujol et al., Markov model as an alternate way to analyse the prognostic information related to tumor markers: Appraisal of CYFRA 21-1 and prognosis of non-small cell lung cancer patients treated by chemotherapy, J TUMOR M, 16(1), 2001, pp. 23-38
Authors:
Daugaard, G
Citation: G. Daugaard, The clinical use of tumor markers in germ cell cancer, J TUMOR M, 16(1), 2001, pp. 39-48
Authors:
Tuxen, MK
Citation: Mk. Tuxen, Tumor marker CA125 in ovarian cancer, J TUMOR M, 16(1), 2001, pp. 49-68
Authors:
Brasso, K
Iversen, P
Citation: K. Brasso et P. Iversen, The clinical utility of prostate specific antigen, J TUMOR M, 16(1), 2001, pp. 69-77
Authors:
Borggaard, BW
Jorgensen, LGM
Citation: Bw. Borggaard et Lgm. Jorgensen, Cancer-related genes, J TUMOR M, 16(1), 2001, pp. 79-84
Authors:
Biava, PM
Bonsignorio, D
Hoxha, M
Citation: Pm. Biava et al., Life-Protecting Factor (LPF): An anti-cancer low molecular weight fractionisolated from pregnant uterine mucosa during embryo organogenesis, J TUMOR M, 15(4), 2000, pp. 223-233
Authors:
Xu, M
Hui, SSC
Zhang, J
Citation: M. Xu et al., Analysis of multidrug resistance-associated protein (MRP) gene and chemosensitivity testing in non small cell lung cancer (NSCLC) patients, J TUMOR M, 15(4), 2000, pp. 235-242
Authors:
Wolk, M
Newlands, ES
Maymon, BBS
Reinus, C
Mitchell, H
Lifschitz-Mercer, B
Citation: M. Wolk et al., Fetal hemoglobin detected serologically and immunohistochemically in cancer patients, J TUMOR M, 15(4), 2000, pp. 243-NIL_4
Authors:
Bhatnagar, PK
Suresh, MR
Citation: Pk. Bhatnagar et Mr. Suresh, Bispecific monoclonal anti-MUC-1 X-anti-peroxidase antibody based breast cancer immunoassay, J TUMOR M, 15(4), 2000, pp. 253-262
Authors:
Morales, LAF
Siritt, MEG
Morales, DEH
Bello, JLA
Citation: Laf. Morales et al., Serial determination of antigalactosyl alpha 1 -> 3 galactose (Anti-Gal) and the tumor marker CA 15-3 in patients with breast cancer, J TUMOR M, 15(4), 2000, pp. 263-273
Authors:
Barak, V
Citation: V. Barak, Cytokeratins as tumor markers, J TUMOR M, 15(3), 2000, pp. 161-161
Authors:
Einarsson, R
Citation: R. Einarsson, Cytokeratins as tumor markers - Molecular and clinical data with focus on TPS, J TUMOR M, 15(3), 2000, pp. 163-169
Authors:
Barak, V
Nisman, B
Hubert, A
Lyass, O
Kaduri, L
Peretz, T
Citation: V. Barak et al., Prognostic efficacy of TPS in breast cancer, J TUMOR M, 15(3), 2000, pp. 171-176
Authors:
Lindman, H
Jansson, T
Arnberg, H
Bergh, J
Einarsson, R
Citation: H. Lindman et al., Serum markers TPS, TPA and CA 15-3 as monitors of chemotherapy in patientswith metastatic breast cancer, J TUMOR M, 15(3), 2000, pp. 177-186
Authors:
van Dalen, A
Einarsson, R
Citation: A. Van Dalen et R. Einarsson, Cytokeratin markers TPS, TPA and CYFRA in epithelial ovarian cancer, J TUMOR M, 15(3), 2000, pp. 187-194